Committee Decisions

To support the cost effective prescribing of oral contraceptives, a resource has been developed to identify the locally preferred products for both combined and progestogen-only contraceptives.

See document: NHS Pharmacy Contraception Service - local product recommendations.

The recommendations are applicable to both general practice and community pharmacy colleagues and is intended to highlight the locally preferred products and those that are less preferred.

OptimiseRx will be utilised to reinforce these recommendations in general practice.

To support the cost effective prescribing of oral contraceptives, a resource has been developed to identify the locally preferred products for both combined and progestogen-only contraceptives.

See document: NHS Pharmacy Contraception Service - local product recommendations.

The recommendations are applicable to both general practice and community pharmacy colleagues and is intended to highlight the locally preferred products and those that are less preferred.

OptimiseRx will be utilised to reinforce these recommendations in general practice.

NHS Pharmacy Contraception Service

To support the cost effective prescribing of oral contraceptives, a resource has been developed to identify the locally preferred products for both combined and progestogen-only contraceptives.

See document: NHS Pharmacy Contraception Service - local product recommendations.

The recommendations are applicable to both general practice and community pharmacy colleagues and is intended to highlight the locally preferred products and those that are less preferred.

OptimiseRx will be utilised to reinforce these recommendations in general practice.

The Primary Care Medicines Optimisation Clinical reference Group approved a number of resources to support care homes in managing the administration, including self-administration, of medicines

See resources below

The Primary Care Medicines Optimisation Clinical reference Group approved a number of resources to support care homes in managing the transfer of care around medicines.

See resources below

The Primary Care Medicines Optimisation Clinical reference Group approved a resource to support care homes in ordering repeat presriptions for inhalers.

See resource below

Several companies are now offering prescribing services to practices that will provide a non-medical prescribing (NMP) pharmacist to cover some of the practice prescribing needs remotely. This is different to arrangements for employing pharmacists directly to work within the PCN or practice through ARRS funding to meet the requirements of the PCN DES. Before entering any such arrangement practices should be aware of appropriate governance arrangements and processes to follow.

The document below ("Outsourcing repeat prescribing services") provides advice for any practice considering thes services.

Advice relating to the use of prescribing cost centres and codes can be found here: https://surreyccg.res-systems.net/PAD/Guidelines/Detail/4979

Licensed phenelzine 15mg tablets have now returned to the market following a period of supply problems, during which, the only available phenelzine preparations were unlicensed tablets and capsules.

However, there is currently no Traffic Light Status within Surrey Heartlands for Monoamine-Oxidase Inhibitors (MAOIs). 

It is recommended that the prescribing remains with the specialist until discussions have been held by the Area Prescribing Committee.

Please refer to the document below for further context

Guide to Managing Requests from NHS Providers outside of Surrey Heartlands where there is a conflict between our Traffic Light Status and their formulary.

The aim of this tool is to support prescribing decisions where our local Traffic Light status is in conflict with the status from a requesting organisation who is not represented at the Surrey Heartlands APC e.g. tertiary centre.

Refer to this guide and associated template letters for support.